Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT randomized controlled trial
The drug is presently in Phase III obesity clinical trials and is expected to launch by 2027
Competing interests The authors declare no competing interests
If you didnt stop your medication, let your team know
We recently partnered with a leading software company to combine behavioral support with targeted GLP1 access
Visual Learning and Practice Support Pictures and videos can make hand placement easier to understand, but they should match the current pen instructions
;Resize=(606,341))
US$ 23.09
US$ 20.91
US$ 28.59
US$ 20.13
US$ 27.03
US$ 24.81
US$ 25.44
US$ 25.94
US$ 28.68
US$ 22.39
